Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 578Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

ORIGINAL ARTICLE

Striking balance between expedited review and expecting efficacious anticancer drug and biologics: An ongoing challenge

Chary Krishnan Vengadaragava, Ramesh Anita

Year : 2017| Volume: 8| Issue : 4 | Page no: 176-179

   This article has been cited by
 
1 The Potential Benefit of Expedited Development and Approval Programs in Precision Medicine
Ariel Kantor,Susanne B. Haga
Journal of Personalized Medicine. 2021; 11(1): 45
[Pubmed]  [Google Scholar] [DOI]

 

Read this article